No Detail Found!

Enhancement and Impairment of Cognitive Behaviour in Morris Water Maze Test by Methylphenidate to Rats.

Author(s)
Tabinda Salman Dr. Panjwani Center for Molecular Medicine and Drugs Research, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, Pakistan
Shazia Nawaz Dr. Panjwani Center for Molecular Medicine and Drugs Research, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, Pakistan
Huma Ikram Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan
Darakhshan Jabeen Haleem Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan ; Dr. Panjwani Center for Molecular Medicine and Drugs Research, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, Pakistan
Abstract
Methylphenidate (MPD), a psycho-stimulant is a prescription medicine for the treatment of Attention deficit hyperactivity disorder (ADHD). The drug is also being increasingly used by general population for enhancing cognition. Only few preclinical studies have been carried out on the effects of MPD on cognition and these studies show either an enhancement or impairment of memory following the administration of MPD. The present study was designed to evaluate the effects of different doses of methylphenidate on acquisition and retention of memory in Morris water-maze test. Twenty four male Albino Wistar rats (weighing 180-220gm) were randomly assigned to four groups: (1) Control (2) 0.5mg/kg (3) 2.5mg/kg (4) 5 mg/kg methylphenidate. Animals received drug or water orally before training phase. Memory acquisition was monitored 2hrs post drug administration while memory retention was determined next day. It was found that the clinically relevant doses of methylphenidate (0.5mg/kg and 2.5mg/kg) improved memory acquisition and its retention but higher dose (5mg/kg) impaired both. We suggest that MPD-induced increase of catecholamine neurotransmission may have a role in the improvement of water maze performance while agonist activity of the drug for 5HT-1A receptor in the impaired performance at high doses. Food intake and body weight changes were not affected by MPD administration due to short-term administration of the drug. Results may help in improving pharmaco-therapeutic use of MPD for ADHD.
Publication Details
Page(s) 899-903
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 32, Issue: 3, Year: 2019

Request the full text from PASTIC

0

Citations

0

Downloads

75

Views